ClinConnect ClinConnect Logo
Search / Trial NCT05977491

Point-of-care Tests for Vaginal Discharge in Nepal

Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Jul 26, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Antibiotic Overtreatment Psychosomatic Domestic Violence Anxiety And Depression Chlamydia Trachomatis Neisseria Gonorrhoea Trichomonas Vaginalis Bacterial Vaginosis Process Evaluation Point Of Care Test

ClinConnect Summary

This clinical trial, taking place in Nepal, is looking at how new testing methods can help women with vaginal discharge. The main goal is to see if using quick tests for sexually transmitted infections (STIs) can reduce the unnecessary use of antibiotics, which are often prescribed even when not needed. The study will involve 1,500 women who visit a hospital or outreach centers in a semi-rural area of Nepal. Participants will be divided into three groups: one will receive the standard treatment, another will get treatment based on the test results, and the third will receive the test-based treatment along with education about their condition and support for any emotional challenges they may face.

To be eligible for this trial, women must be 18 years or older and experiencing vaginal discharge when they visit the gynecologist. However, those with bleeding, suspected gynecological cancer, or who were part of the study before cannot participate. Throughout the study, participants can expect to receive care based on the approach assigned to their group, and the researchers will also gather feedback on how well these tests are accepted by both patients and healthcare providers. This trial aims to improve the treatment of vaginal discharge and ensure that women receive the right care without unnecessary medications.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women presenting with vaginal discharge to gynecological outpatients
  • Exclusion Criteria:
  • Minors below the age of 18 years.
  • Any bleeding from the vagina.
  • Suspicion of gynecological cancer.
  • Previous inclusion in the same study.

About Norwegian University Of Science And Technology

The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.

Locations

Dhulikhel, Kavre, Nepal

Patients applied

0 patients applied

Trial Officials

Risa AM Lonnee-Hoffmann, PhD

Principal Investigator

Norwegian University for Science and Technology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported